Page last updated: 2024-08-23

pravastatin and 13-hydroxy-9,11-octadecadienoic acid

pravastatin has been researched along with 13-hydroxy-9,11-octadecadienoic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cadnapaphornchai, MA; Christians, U; Gitomer, B; Klawitter, J; McFann, K; Pennington, AT; Schrier, RW; Wang, W	1

Trials

1 trial(s) available for pravastatin and 13-hydroxy-9,11-octadecadienoic acid

Article	Year
Pravastatin Therapy and Biomarker Changes in Children and Young Adults with Autosomal Dominant Polycystic Kidney Disease. Clinical journal of the American Society of Nephrology : CJASN, 2015, Sep-04, Volume: 10, Issue:9 Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adolescent; Biomarkers; Child; Female; Humans; Hydroxyeicosatetraenoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linoleic Acids; Male; Organ Size; Oxidative Stress; Polycystic Kidney, Autosomal Dominant; Pravastatin; Time Factors; Young Adult	2015

Article

Year

Pravastatin Therapy and Biomarker Changes in Children and Young Adults with Autosomal Dominant Polycystic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN, 2015, Sep-04, Volume: 10, Issue:9

Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adolescent; Biomarkers; Child; Female; Humans; Hydroxyeicosatetraenoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linoleic Acids; Male; Organ Size; Oxidative Stress; Polycystic Kidney, Autosomal Dominant; Pravastatin; Time Factors; Young Adult

2015